Vercirnon
Vercirnon (Traficet-EN) is a potent and selective CCR9 antagonist with an IC50 of 10 nM. It is a valuable research tool for studying inflammatory bowel disease (IBD), utilized in both in vitro assays and in vivo preclinical models to investigate CCR9-mediated immune cell migration.
Product Specifications
CAS Number
698394-73-9
Product Name Alternative
Inhibitor, GSK1605786, GSK-1605786, GSK 1605786, oral, inflammatory, inhibit, disease, chemokine, CC chemokine receptor, CCX282-B, CCR9, CCR, chemotaxis, bioavailable, bowel, Traficet-EN, Vercirnon
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
99.15% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:1.5 mg/mL (3.37 mM) ; DMSO:15 mg/mL (33.71 mM)
Smiles
CC (C) (C) c1ccc (cc1) S (=O) (=O) Nc1ccc (Cl) cc1C (=O) c1cc[n+] ([O-]) cc1
Molecular Formula
C22H21ClN2O4S
Molecular Weight
444.93
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15093435 1 Vial
Lentiviral human LALBA shRNA (UAS) - Lentiviral human LALBA shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details